9:21 PM
 | 
Jan 03, 2019
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Months after Hong Kong proposal, Stealth now seeking NASDAQ listing

Stealth BioTherapeutics Corp. (Newton, Mass.) proposed an IPO on NASDAQ late on Dec. 28, less than six months after filing to list on the Hong Kong stock exchange. The prospectus filed with the SEC on Dec. 28 does not mention a dual listing, and Stealth has yet to conduct a Hong Kong offering.

Stealth is developing therapies for diseases involving mitochondrial dysfunction. Its lead candidate,...

Read the full 301 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >